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Introduction
Within-person variation in headache (HA) frequency and
the nature and predictors of this variation have rarely been
studied.
Aims
To determine variation and predictors of HA days/month
in persons with episodic (EM) or chronic migraine (CM).
Methods
CaMEO was a longitudinal US survey employing quota
sampling for screening 80,783 respondents to identify
persons with migraine. Baseline HA day frequency was
classified as EM (modified ICHD-3b migraine diagnosis,
<15 HA days/month for past 3 months) or CM (modified
ICHD-3b diagnosis, ≥15 HA days/month for past
3 months). Migraineurs completed quarterly surveys over
5 waves (~1 year) assessing HA symptoms and frequency.
Using repeated measures regression modeling, we
describe variation in HA days within/between individuals,
and evaluate potential variation predictors.
Results
From 58,418 useable returns, we identified 16,789 migrai-
neurs at baseline (EM: 15,313 [91.2%], CM: 1,476 [8.8%]).
The reported number of HA days/month showed cyclic
variation over time within and between respondents with
both CM and EM. HA days increased more for CM (vs
EM) persons over time (quarterly RR=1.26, 95% CI
1.20–1.33; P<0.0001). A comprehensive graphical decom-
position of this interaction will be presented.
Conclusion
Substantial within- and between-person heterogeneity in
quarterly estimates of HA days/month was observed, and
resulting trajectories differed between groups. The number
of HA days/month increased 26% more per quarter for
persons with CM vs EM, possibly resulting from a lowered
threshold for migraine initiation, creating positive feed-
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